Nectero Therapeutics

Raises and deals from press releases

• Raise Series D · $96M · announced Apr 11, 2024 Company release ↗
  Source quote

  • Apr 11, 2024 · Company release ↗
    “TEMPE, Ariz.–( BUSINESS WIRE )– Nectero Therapeutics, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, today announced the closing of its $96 million Series D financing round.”

Raises announced in these releases: $96M disclosed.

From the company’s own releases; this list is partial. All raises and deals